A Clinical Study Finds Pfizer's Dacomitinib Delays The Growth of Lung Cancer Cells Better Than AstraZeneca's Iressa Medicine & Technology Jun 06, 2017 In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
Plato’s Long-Lost Grave Found Using AI To Decipher Herculaneum Scrolls; Greek Philosopher Had Been Sold Into Slavery: Report
UFOs Piloted by Spiritual Entities? Fox News' Tucker Carlson Makes Bizarre Claim, Suggests That They Do Not Behave According to Laws of Science
SPACE Japan’s Moon Lander Woke Up for a Third Time After Surviving Another Frigid Two-Week Lunar Night